Purchase Order HHSF223201810025A

Award Date 1/4/18
Potential Completion Date 2/9/22
Potential Value $96K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a genetic analyzer with a 4-year post-warranty maintenance option, with a ceiling value of $80,335.95 and a completion date of September 14, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
The Department of Health and Human Services Food and Drug Administration awarded a $918,227.19 firm-fixed-price definitive contract to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the provision of genetic analyzers, warranty, and maintenance services. The contract has an April 26, 2024 completion date and was awarded on April 18, 2019 without the use of a set-aside. Life Technologies Corporation, a leading provider of biomedical research and genetic analysis...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is valued at $153,142.00 and runs through June 6, 2027. The contract is for Life Technologies to perform molecular analyses of bacteria isolated from regulatory samples using the ABI7500 Fast Real-Time PCR system. This specialized laboratory equipment is critical for the FDA's Office of Regulatory Affairs...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract, valued at $186,112.65, is for the provision of AB 7500 FAST PM SERVICE AGREEMENT to support the FDA's mission and activities. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools, specializing in the delivery of scientific products, including specialized...
This federal contract award, valued at $80,606.37, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to procure a live cell imaging system. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. The contract does not involve any set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, and...
This is a firm fixed-price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the maintenance of two genetic analyzers and one PCR system. The contract has a base period plus four option years, with a total ceiling value of $79,824.33. No set-aside was used for this award. The contract supports scientific research and testing capabilities for...
This federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, is for the maintenance, repair, and service of ATTUNE NXT with Autosampler flow cytometry equipment. The $11,052.99 firm fixed price contract has a completion date of January 13, 2026 and was awarded by the Food and Drug Administration (FDA), a civilian agency, on January 7, 2025. This award is not associated with a set-aside or larger contract vehicle. Life Technologies is a leading...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for a MICROSEQ GENETIC ANALYZER. The $323,879.64 award does not have a set-aside designation and was made on August 24, 2017 with a completion date of August 23, 2021. As a division of Thermo Fisher Scientific, Life Technologies serves as a prime contractor across various federal...
This is a $82,231.05 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The award is for an Automated Express Nucleic Acid Extraction System, which supports the FDA's mission in medical research, disease prevention, and healthcare. The contract has no set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools to...
This is a firm fixed-price purchase order for DNA analyzer maintenance services awarded by the Office of Acquisitions and Grants to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is valued at $97,889.15 and has an ultimate completion date of October 13, 2025. The services cover maintenance of the ABI PRISM 3730 DNA Analyzer for the customer agency. This award is not associated with a set-aside program. As a manufacturer of scientific instruments and...

This is a federal contract award from the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for $95,672.40 to provide genetic analyzer corrective/remedial repair and preventive maintenance services. The contract has a period of performance through February 9, 2022 and is a firm fixed price purchase order. There is no set-aside designation. Life Technologies has established itself as a prime contractor across multiple federal agencies, providing a variety of specialized scientific instruments, reagents, and analytical services to support research, public health, and safety initiatives. This contract supports the FDA's ongoing requirements for maintaining and repairing genetic analysis equipment used in their programs.

Generated 4/3/25, 12:27 AM